Nipah Virus Infection Market
- 2026 年市場規模
- USD 54.8 Mn
- 2033 年預估規模
- USD 123.6 Mn
- 年複合成長率 CAGR
- 12.32%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Nipah Virus Infection Market, By Product Type (Assay kits, Instruments/Analyzers, and Reagents and Consumables), By Test Type (Molecular Tests, Serology Tests, Antigen-Detection Tests, and Confirmatory/Specialized Tests), By Technology Platform (PCR-Based Testing, ELISA, Lateral Flow, Next-Generation Sequencing, and Others), By Sample Type (Blood/ Serum, Urine, Cerebrospinal Fluid (CSF), Throat Swab, and Nasal Swab), By End User (Hospitals and Infectious Disease Centers, Public Health Agencies, Reference Laboratories, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)
報告摘要
The global Nipah virus infection market is estimated to be valued at USD 54.8 Mn in 2026 and is expected to reach USD 123.6 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 12.32% from 2026 to 2033. The global Nipah virus infection market is an important segment in the infectious disease management domain, which targets one of the most critical infectious diseases identified in recent times.
Nipah virus infection, first identified during an epidemic in Malaysia in 1998, is a paramyxovirus that results in severe encephalitis and respiratory disease in infected human beings, with a case fatality rate ranging between 40% and 75%. The disease spreads from infected fruit bats to human beings, either through an intermediate host, such as pigs, or through direct contact with infected bat secretions, thereby becoming a major cause of public health concern in endemic countries such as Bangladesh, India, and Southeast Asia.
The market has attracted significant attention owing to the high potential of the virus to cause a pandemic and its inclusion as a priority pathogen by the WHO, thereby emphasizing the need for R&D. The rising incidence rate of zoonotic disease outbreaks, combined with the increased recognition of biosecurity threats and the improvement in surveillance, is contributing to the continued investment by pharmaceutical companies, biotechnology companies, and public health organizations, thereby creating an innovative market scenario in the case of Nipah virus infection.
Market Dynamics
The global market for Nipah virus infection is influenced by the rising incidence rate of zoonotic infections, the global focus on pandemic preparedness, and the increased government and international funding levels for emerging infectious diseases. The WHO's categorization of the Nipah virus as a priority pathogen is driving the growth of the market, as is the increased funding support from organizations such as the Coalition for Epidemic Preparedness Innovations (CEPI) for the development of vaccines against the Nipah virus.
Moreover, the increased rate of urbanization and deforestation in endemic regions is driving the market, as the increased rate of interaction between animals and humans is elevating the risk of the spread of the infection. The increased rate of technological advancements in the molecular diagnostics market, especially in the case of real-time PCR and next-generation sequencing, is driving the market.
However, the market is also affected by significant restraints, especially because of the sporadic and localized nature of the infection, causing less commercial interest in investment opportunities in the pharmaceutical market. The high cost of development of vaccines and medicines, along with the difficulties encountered while conducting clinical trials, are significant restraints to the market. The lack of healthcare infrastructure is also a significant restraint to the market, especially in endemic areas.
Even though the market is affected by significant restraints, the market is also affected by significant opportunities for partnerships and collaborations, and the trend of biosecurity is significant and is expected to have positive implications for the potential of the market in the future, especially through the use of One Health and rapid vaccine development technologies.
Key Features of the Study
• This report provides in-depth analysis of the global Nipah virus infection market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global Nipah virus infection market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include BioPerfectus, Molbio Diagnostics, Huwel Lifesciences, BGI Genomics, ELK Biotechnology, Creative Diagnostics, RayBiotech, Abbexa, AntibodySystem, and Alpha Diagnostic Intl
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global Nipah virus infection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Nipah virus infection market
Market Segmentation
• Product Type Insights (Revenue, USD Mn, 2021 - 2033)
o Assay kits
o Instruments/Analyzers
o Reagents and Consumables
• Test Type Insights (Revenue, USD Mn, 2021 - 2033)
o Molecular Tests
o Serology Tests
o Antigen-Detection Tests
o Confirmatory/Specialized Tests
• Technology Platform Insights (Revenue, USD Mn, 2021 - 2033)
o PCR-Based Testing
o ELISA
o Lateral Flow
o Next-Generation Sequencing
o Others
• Sample Type Insights (Revenue, USD Mn, 2021 - 2033)
o Blood/ Serum
o Urine
o Cerebrospinal Fluid (CSF)
o Throat Swab
o Nasal Swab
• End User Insights (Revenue, USD Mn, 2021 - 2033)
o Hospitals and Infectious Disease Centers
o Public Health Agencies
o Reference Laboratories
o Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o BioPerfectus
o Molbio Diagnostics
o Huwel Lifesciences
o BGI Genomics
o ELK Biotechnology
o Creative Diagnostics
o RayBiotech
o Abbexa
o AntibodySystem
o Alpha Diagnostic Intl
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Global Nipah Virus Infection Market, By Product Type
Global Nipah Virus Infection Market, By Test Type
Global Nipah Virus Infection Market, By Technology Platform
Global Nipah Virus Infection Market, By Sample Type
Global Nipah Virus Infection Market, By End User
Global Nipah Virus Infection Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Key Developments
o Industry Trends
4. Global Nipah Virus Infection Market, By Product Type, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Assay kits
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Instruments/Analyzers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Reagents and Consumables
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Nipah Virus Infection Market, By Test Type, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Molecular Tests
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Serology Tests
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Antigen-Detection Tests
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Confirmatory/Specialized Tests
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Nipah Virus Infection Market, By Technology Platform, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o PCR-Based Testing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o ELISA
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Lateral Flow
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Next-Generation Sequencing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Nipah Virus Infection Market, By Sample Type, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Blood/ Serum
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Urine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Cerebrospinal Fluid (CSF)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Throat Swab
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Nasal Swab
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Nipah Virus Infection Market, By End User, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Hospitals and Infectious Disease Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Public Health Agencies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Reference Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Nipah Virus Infection Market, By Region, 2021 - 2033, Value (USD Mn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
o South Africa
o North Africa
o Central Africa
10. Competitive Landscape
o BioPerfectus
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Molbio Diagnostics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Huwel Lifesciences
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o BGI Genomics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o ELK Biotechnology
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Creative Diagnostics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o RayBiotech
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Abbexa
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o AntibodySystem
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Alpha Diagnostic Intl
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
11. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
12. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on 'Nipah Virus Infection Market' - Global forecast to 2033
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們